| Michelle Lee Frei, LAC | |
|
100 6th Ave Se, Mandan, ND 58554-4300 | |
| (701) 663-8228 | |
| (701) 663-0912 |
| Full Name | Michelle Lee Frei |
|---|---|
| Gender | Female |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 100 6th Ave Se, Mandan, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558765024 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | 1456 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Lee Frei, LAC 100 6th Ave Se, Mandan, ND 58554-4300 Ph: (701) 663-8228 | Michelle Lee Frei, LAC 100 6th Ave Se, Mandan, ND 58554-4300 Ph: (701) 663-8228 |
News Archive
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that it has requested Scientific Advice from the European Medicines Agency (EMA) to assure the acceptability of the recently initiated Phase 3 programs for the development of its lead anticancer compound, perifosine, in its two lead indications, multiple myeloma and refractory advanced colorectal cancer.
A virus that destroys cancer cells but leaves normal cells unharmed may offer hope to those affected by squamous cell carcinoma of the lungs (SCC lung cancer), according to investigators from the Cancer Therapy & Research Center (CTRC) at the University of Texas Health Science Center at San Antonio. The CTRC has started patient enrollment in a US Phase 2 clinical trial using intravenous administration of REOLYSIN® in combination with carboplatin and paclitaxel in patients with SCC lung cancer.
Gene therapy holds promise in the treatment of cancer as well as a large number of other diseases. However, developing a scalable system for delivering genes to cells both efficiently and safely has been challenging. Now, two teams of researchers have developed versatile nanotechnology-enabled platforms that could get therapeutic genes safely and efficiently into cancer cells.
A UCLA-led study has found that levels of six proteins in the blood can be used to gauge a person's risk for cerebral small vessel disease, or CSVD, a brain disease that affects an estimated 11 million older adults in the U.S. CSVD can lead to dementia and stroke, but currently it can only be diagnosed with an MRI scan of the brain.
› Verified 8 days ago
Lisa M. Goetz, LPCC Counselor Medicare: Medicare Enrolled Practice Location: 1702 E Main St Ste 101, Mandan, ND 58554 Phone: 701-751-8060 Fax: 701-751-8060 | |
Candace Rivinius, LPCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1702 E Main St Ste 101, Mandan, ND 58554 Phone: 701-751-8060 Fax: 701-751-8060 | |
Kathleen Schmaltz, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 314 W Main St, Mandan, ND 58554 Phone: 701-663-2122 Fax: 701-663-7521 | |
Darrel G Lindensmith, MA MS LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 3030 Old Red Trail St., Mandan, ND 58554 Phone: 701-391-9131 Fax: 701-663-2763 | |
Jeanne Marie Hettich Farnsworth, LPCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 103 Shady Acres St Ne, Mandan, ND 58554 Phone: 605-281-0528 Fax: 701-255-4495 | |
Sloane Floberg, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1702 E Main St Ste 101, Mandan, ND 58554 Phone: 701-751-8060 Fax: 701-751-8060 |